Clinical characteristics of childhood guillain-barré syndrome

Oman Medical Journal
|February 24, 2012
PubMed

Insights

Guillain-Barré syndrome in Omani children under 15 shows low incidence and mortality. While serious, most children recover fully with treatments like intravenous immunoglobulins, which also shorten hospital stays.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases Epidemiology

Background:

  • Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting the peripheral nervous system.
  • Pediatric GBS presents unique challenges in diagnosis and management.

Purpose of the Study:

  • To determine the incidence, clinical presentation, and outcomes of GBS in children under 15 in Oman.
  • To evaluate the effectiveness of treatments in this pediatric population.

Main Methods:

  • A retrospective study of children under 15 with acute flaccid paralysis admitted to identify GBS.
  • Diagnosis confirmed via clinical criteria, cerebrospinal fluid analysis, and nerve conduction studies.
  • Treatment included intravenous immunoglobulins and plasmapheresis for select cases.

Main Results:

  • Sixty-one children (20% of acute flaccid paralysis cases) were diagnosed with GBS.
  • Annual incidence was 0.45 per 100,000 children under 15.
  • Cranial nerve involvement occurred in 50.8%, and 18.3% required ventilation. Complete recovery averaged 69.1 days, with no mortality.

Conclusions:

  • GBS is a significant pediatric neurological condition in Oman with a favorable prognosis.
  • Prompt treatment with immunoglobulins can reduce recovery time and hospital stay.
  • Long-term morbidity is low, emphasizing the importance of early diagnosis and management.
Abstract

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...